Lingual Haematoma due to Tenecteplase in a Patient with Acute Myocardial Infarction

Abstract EN

The use of intravenous thrombolytic agents has revolutionised the treatment of acute myocardial infarction.

However, the improvement in mortality rate achieved with these drugs is tempered by the risk of serious bleeding complications, including intracranial haemorrhage.

Tenecteplase is a genetically engineered mutant tissue plasminogen activator.

Haemorrhagic complications of tissue plasminogen activator (tPA) are well known.

Compared to other tPAs, tenecteplase use leads to lower rates of bleeding complications.

Here, we report a case of unusual site of spontaneous bleeding, intralingual haematoma during tenecteplase therapy following acute myocardial infarction, which caused significant upper airway obstruction and required tracheotomy to maintain the patient’s airway.

Clinical dilemmas related to securing the airway or reversing the effects of tissue plasminogen activator are discussed.